2023
Alterations in Cancer Treatment During the First Year of the COVID-19 Pandemic in the US
Janczewski L, Cotler J, Merkow R, Palis B, Nelson H, Mullett T, Boffa D. Alterations in Cancer Treatment During the First Year of the COVID-19 Pandemic in the US. JAMA Network Open 2023, 6: e2340148. PMID: 37902756, PMCID: PMC10616721, DOI: 10.1001/jamanetworkopen.2023.40148.Peer-Reviewed Original ResearchConceptsNational Cancer DatabaseCancer treatmentAcademic hospitalCommunity hospitalMAIN OUTCOMECOVID-19 pandemicProportion of patientsRetrospective cohort studyAvailability of treatmentFirst yearUnderwent surgeryCohort studyMedian ageCancer surgeryMedian timeTreatment of cancerCancer careTreatment modalitiesCancer screeningCancer DatabaseMedian travel distancePatientsHospitalSurgeryCancerEffect of pandemic-related reductions in cancer care delivery on different US health systems.
Janczewski L, Cotler J, Merkow R, Palis B, Nelson H, Mullett T, Boffa D. Effect of pandemic-related reductions in cancer care delivery on different US health systems. Journal Of Clinical Oncology 2023, 41: e18811-e18811. DOI: 10.1200/jco.2023.41.16_suppl.e18811.Peer-Reviewed Original ResearchNational Cancer DatabaseHospital typeAcademic hospitalUS healthcare systemTreatment modalitiesCommunity hospitalTreatment utilizationCancer treatmentCOVID-19 pandemicCancer care deliveryTypes of malignanciesHealthcare systemDifferent hospital typesEvaluation of cancerChi-squared testUS health systemFirst yearUnderwent surgerySurgical patientsCancer careCancer DatabaseSurgical carePatientsTreatment declineDescriptive univariate statistics
2016
Role of Adjuvant Therapy for Node-Negative Lung Cancer Invading the Chest Wall
Gao SJ, Corso CD, Blasberg JD, Detterbeck FC, Boffa DJ, Decker RH, Kim AW. Role of Adjuvant Therapy for Node-Negative Lung Cancer Invading the Chest Wall. Clinical Lung Cancer 2016, 18: 169-177.e4. PMID: 27890561, DOI: 10.1016/j.cllc.2016.08.005.Peer-Reviewed Original ResearchConceptsNon-small cell lung cancerAdjuvant chemotherapyAdjuvant chemoradiation therapyUnderwent surgeryChemoradiation therapyChest wall resectionRadiation therapyMargin statusTumor sizeLung cancerWall resectionNode-negative lung cancerNational Cancer Data BaseCox proportional hazards modelMargin-positive patientsChest wall invasionCell lung cancerLog-rank testStage IIB tumorsProportional hazards modelAdjuvant therapyAdjuvant treatmentOverall survivalMultivariable analysisIIB tumors